VINCERX PHARMA INC (VINC)
US92731L1061 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-6-30) | 2019 (2019-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -40.16M | -65.37M | -39.31M | -120.00K | 0.00 | |||
| Depreciation Amortization | 52.00K | 50.00K | 30.00K | N/A | N/A | |||
| Change In Working Capital | -4.19M | -1.02M | 5.61M | 10.00K | 0.00 | |||
| Interest Paid | 0.00 | 0.00 | 30.00K | 30.00K | N/A | |||
| Taxes Paid | 0.00 | N/A | N/A | 0.00 | N/A | |||
| Other non cash items | 3.84M | 6.73M | 270.00K | -50.00K | N/A | |||
| OPERATING CASH FLOW | -40.45M | -59.60M | -33.40M | -170.00K | 0.00 | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -260.00K | N/A | N/A | |||
| Other Investing Activity | 41.50M | -40.58M | -5.00M | -65.64M | N/A | |||
| INVESTING CASH FLOW | 41.50M | -40.58M | -5.26M | -65.64M | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | N/A | |||
| Stock Issued/Repurchased | 114.00K | 280.00K | 88.45M | 65.86M | 30.00K | |||
| Other Financing Activity | N/A | N/A | N/A | 600.00K | 0.00 | |||
| FINANCING CASH FLOW | 114.00K | 280.00K | 88.45M | 66.46M | 30.00K | |||
| Exchange Rate Effect | -40.00K | 70.00K | -20.00K | N/A | N/A | |||
| CHANGE IN CASH | 1.12M | -99.83M | 49.77M | 650.00K | 30.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -40.45M | -59.60M | -33.40M | -170.00K | 0.00 | |||
| Capital Expenditure | N/A | 0.00 | -260.00K | N/A | N/A | |||
| FREE CASH FLOW | -40.45M | -59.60M | -33.66M | -170.00K | 0.00 | |||
All data in USD